CannTrust Holdings Incorporated (TSX:TRST)(NYSE:CTST), a federally licensed provider of medical cannabis, has named Greg Guyatt as its new chief executive officer, it was reported on Thursday.
Guyatt is the firm's present chief financial officer and will replace interim CEO, Robert Marcovitch.
Guyatt joined CannTrust in February 2019 as chief financial officer and is a Chartered Professional Accountant. He earlier served as the CFO of GreenSpace Brands Inc and has around 25 years of experience leading finance teams from the consumer packaged goods, pharmaceutical, and private equity sectors.
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar
Novo Nordisk expands legal action over compounded 'semaglutide'
Neuraxpharm launches Neuraxpharm Australia
OncoZenge selects Meribel Pharma as CDMO for Phase 3 BupiZenge project
Fridays nominated for World Out of Home awards for weight loss campaign
Physiomics expands into biometrics with two contract wins and new division head